Altogether, the lack of positive expression correlations of FOXL2 and GATA4 in the more aggressive GCTs suggests that imbalances in FOXL2-GATA4-SMAD3 expression might increase the growth potential of GCTs, leading to a more aggressive tumor behavior. Here, FOXL2 is linked to neoplasm.